Santa Cruz Biotechnology now offers a broad range of ERK 2 Activators. Mitogen-activated protein kinase (MAPK) signaling pathways involve two closely related MAP kinases, known as extracellular-signal-related kinase 1 (ERK 1, p44) and 2 (ERK 2, p42). Growth factors, steroid hormones, G protein-coupled receptor ligands, and neurotransmitters can initiate MAPK signaling pathways. Activation of ERK1 and ERK2 requires phosphorylation by upstream kinases such as MAP kinase kinase (MEK), MEK kinase and Raf-1. ERK 2 Activators offered by Santa Cruz activate ERK 2 and, in some cases, other proliferation and transcription regulation related proteins. View detailed ERK 2 Activator specifications, including ERK 2 Activator CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
t-Butylhydroquinone | 1948-33-0 | sc-202825 | 10 g | $67.00 | 4 | |
t-Butylhydroquinone is a potent antioxidant that exhibits unique interactions with cellular signaling pathways, particularly through its influence on ERK 2 activation. It engages in specific redox reactions, facilitating the modulation of reactive oxygen species levels, which in turn affects downstream signaling cascades. Its distinct kinetic profile allows for rapid engagement with target molecules, enhancing its role in cellular defense mechanisms and influencing various metabolic processes. | ||||||
U-46619 | 56985-40-1 | sc-201242 sc-201242A | 1 mg 10 mg | $245.00 $1301.00 | 40 | |
U-46619 is a selective agonist that uniquely modulates the ERK 2 signaling pathway, influencing cellular responses through specific receptor interactions. Its structure allows for distinct binding affinities, leading to differential activation of downstream effectors. The compound exhibits unique reaction kinetics, promoting rapid phosphorylation events that alter gene expression profiles. Additionally, U-46619's interactions with lipid membranes can affect cellular permeability and signal transduction efficiency. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
C2 Ceramide acts as a potent modulator of the ERK 2 pathway, engaging in specific protein-protein interactions that enhance signal transduction. Its unique structural features facilitate selective binding to target kinases, resulting in distinct phosphorylation patterns. The compound's dynamic behavior in cellular environments influences membrane fluidity and alters the kinetics of downstream signaling cascades, ultimately impacting cellular fate decisions. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin, after binding to its receptor, activates a series of intracellular signaling cascades, including the PI3K/AKT and the Ras/Raf/MEK/ERK pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP 2 is a selective inhibitor of the ERK 2 pathway, characterized by its ability to disrupt specific phosphorylation events through competitive binding. Its unique conformation allows for targeted interactions with key regulatory proteins, modulating their activity. The compound exhibits distinct reaction kinetics, influencing the rate of downstream signaling events. Additionally, PP 2's solubility properties enhance its distribution within cellular compartments, affecting overall pathway dynamics. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II, Human, acts as a potent activator of the ERK 2 signaling pathway, facilitating critical phosphorylation processes. Its unique structure enables specific interactions with receptor tyrosine kinases, triggering a cascade of intracellular responses. The compound's rapid kinetics promote swift activation of downstream effectors, influencing cellular proliferation and differentiation. Furthermore, its affinity for membrane-bound receptors enhances its localization and efficacy in modulating signaling networks. | ||||||
Baicalin | 21967-41-9 | sc-204638 sc-204638A sc-204638B sc-204638C | 1 mg 25 mg 1 g 5 g | $56.00 $112.00 $224.00 $265.00 | 4 | |
Baicalin is a flavonoid that modulates the ERK 2 pathway through its ability to interact with various kinases and phosphatases. Its unique hydroxyl groups facilitate hydrogen bonding, enhancing binding affinity to target proteins. This compound influences the phosphorylation state of key substrates, thereby regulating cellular responses. Additionally, its role in oxidative stress modulation can impact reaction kinetics, further influencing signaling dynamics within the cell. | ||||||
L-α-Lysophosphatidylcholine (from egg yolk) | 9008-30-4 | sc-473611 sc-473611A sc-473611B sc-473611C | 25 mg 100 mg 500 mg 1 g | $87.00 $235.00 $607.00 $1102.00 | 1 | |
L-α-Lysophosphatidylcholine, derived from egg yolk, is a phospholipid that plays a pivotal role in cellular signaling by modulating the ERK 2 pathway. Its unique amphiphilic structure allows it to interact with membrane proteins, influencing lipid bilayer dynamics and facilitating protein-lipid interactions. This compound can alter membrane fluidity, impacting the localization and activity of signaling molecules, thereby affecting downstream phosphorylation events and cellular responses. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin acts as a JNK activator, which can indirectly upregulate ERK2 expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, which paradoxically can lead to upregulation of ERK expression, possibly as a compensatory response. | ||||||